Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective
Crossref DOI link: https://doi.org/10.1007/s40273-015-0296-5
Published Online: 2015-05-29
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Simpson, Emma L.
Davis, Sarah
Thokala, Praveen
Breeze, Penny R.
Bryden, Peter
Wong, Ruth
Funding for this research was provided by:
National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (12/56/01 STA)
Text and Data Mining valid from 2015-05-29